LPL Financial
TXG icon

LPL Financial’s 10x Genomics TXG Stock Holding History

LPL Financial’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.06M Buy
157,979
+94,730
+150% +$2.48M ﹤0.01% 2612
2026
Q1 		$1.34M Buy
63,249
+1,214
+2% +$24.3K ﹤0.01% 3884
2025
Q4 		$1.01M Sell
62,035
-60,185
-49% -$909K ﹤0.01% 4063
2025
Q3 		$1.43M Buy
122,220
+75,275
+160% +$981K ﹤0.01% 3646
2025
Q2 		$544K Buy
46,945
+432
+0.9% +$3.94K ﹤0.01% 4307
2025
Q1 		$406K Buy
46,513
+12,742
+38% +$161K ﹤0.01% 4355
2024
Q4 		$485K Buy
33,771
+7,014
+26% +$111K ﹤0.01% 4118
2024
Q3 		$604K Buy
26,757
+8,028
+43% +$166K ﹤0.01% 3836
2024
Q2 		$364K Buy
18,729
+697
+4% +$18.3K ﹤0.01% 4115
2024
Q1 		$677K Buy
18,032
+6,859
+61% +$301K ﹤0.01% 3517
2023
Q4 		$625K Buy
11,173
+3,307
+42% +$144K ﹤0.01% 3484
2023
Q3 		$324K Sell
7,866
-5,802
-42% -$302K ﹤0.01% 3846
2023
Q2 		$763K Buy
13,668
+6,164
+82% +$334K ﹤0.01% 3087
2023
Q1 		$419K Sell
7,504
-7,856
-51% -$367K ﹤0.01% 3481
2022
Q4 		$560K Sell
15,360
-3,067
-17% -$100K ﹤0.01% 3150
2022
Q3 		$525K Sell
18,427
-3,146
-15% -$120K ﹤0.01% 3114
2022
Q2 		$976K Buy
21,573
+1,660
+8% +$86.1K ﹤0.01% 2594
2022
Q1 		$1.51M Buy
19,913
+3,611
+22% +$316K ﹤0.01% 2260
2021
Q4 		$2.43M Buy
16,302
+7,425
+84% +$1.14M ﹤0.01% 1941
2021
Q3 		$1.29M Sell
8,877
-751
-8% -$129K ﹤0.01% 2412
2021
Q2 		$1.89M Buy
9,628
+629
+7% +$114K ﹤0.01% 2035
2021
Q1 		$1.63M Buy
8,999
+1,972
+28% +$341K ﹤0.01% 1996
2020
Q4 		$995K Buy
7,027
+3,503
+99% +$508K ﹤0.01% 2187
2020
Q3 		$439K Buy
+3,524
New +$370K ﹤0.01% 2578

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial's TXG Position: Q2 2026 in Review

LPL Financial increased its 10x Genomics (TXG) stake by 150% in Q2 2026, buying an estimated $2.48M and bringing the position to 157,979 shares worth $6.06M. The position accounts for ﹤0.01% of the portfolio, ranked #2612.

LPL Financial first reported a position in TXG in Q3 2020 and has held it in 24 quarters since. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • LPL Financial held 157,979 shares of 10x Genomics worth $6.06M as of Q2 2026.
  • LPL Financial bought 94,730 10x Genomics shares in Q2 2026, an estimated $2.48M.
  • 10x Genomics made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #2612 holding.
  • LPL Financial first reported a position in 10x Genomics in Q3 2020 and has held it in 24 quarters since.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.